Opinion: Cannabidiol confusion: lofty promises and barriers to research
As cannabis researchers, we work in a field whose unknowns could positively or negatively affect the health of millions of Americans. But the U.S. government’s decades-long prohibition of cannabis research forcefully limits what we might learn. Adding to the absurdity, the recent relaxation of this prohibition may promote a public health threat.
A recent by former Food and Drug Administration Commissioner Scott Gottlieb raised compelling points about products containing cannabidiol (CBD), a non-intoxicating molecule made by the cannabis plant. It also exposed our policymakers’ dysfunctional lack of discernment between the . Today, cannabis is federally criminalized and research into its potential medical value , while hemp products are widely commercialized with almost no oversight.
You’re reading a preview, subscribe to read more.
Start your free 30 days